Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus.

× No keyword cloud information.

7 in total

1. Risk Factors for Atrial Fibrillation in People With Type 1 Diabetes: An Observational Cohort Study of 36,258 Patients From the Swedish National Diabetes Registry.

Authors: Sara Hallström; Aldina Pivodic; Annika Rosengren; Arndís F Ólafsdóttir; Ann-Marie Svensson; Marcus Lind
Journal: Diabetes Care Date: 2019-06-06 Impact factor: 19.112

Review 2. Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week.

Authors: Allen Wang; Jennifer B Green; Jonathan L Halperin; Jonathan P Piccini
Journal: J Am Coll Cardiol Date: 2019-08-27 Impact factor: 24.094

3. No evidence of a causal association of type 2 diabetes and glucose metabolism with atrial fibrillation.

Authors: Hadi Harati; Daniela Zanetti; Abhiram Rao; Stefan Gustafsson; Marco Perez; Erik Ingelsson; Joshua W Knowles
Journal: Diabetologia Date: 2019-02-27 Impact factor: 10.122

4. Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan.

Authors: Chia-Yu Chang; Yung-Hsin Yeh; Yi-Hsin Chan; Jia-Rou Liu; Shang-Hung Chang; Hsin-Fu Lee; Lung-Sheng Wu; Kun-Chi Yen; Chi-Tai Kuo; Lai-Chu See
Journal: Cardiovasc Diabetol Date: 2017-12-19 Impact factor: 9.951

5. Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis.

Authors: Arnaud Bisson; Alexandre Bodin; Grégoire Fauchier; Julien Herbert; Denis Angoulvant; Pierre Henri Ducluzeau; Gregory Y H Lip; Laurent Fauchier
Journal: Cardiovasc Diabetol Date: 2021-01-22 Impact factor: 9.951

6. Antihyperglycemic drugs use and new-onset atrial fibrillation: A population-based nested case control study.

Authors: Yi-Sheng Liou; Fu-Yu Yang; Hung-Yi Chen; Gwo-Ping Jong
Journal: PLoS One Date: 2018-08-30 Impact factor: 3.240

7. SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials.

Authors: Wen-Jie Li; Xing-Qing Chen; Ling-Ling Xu; Yuan-Qing Li; Bi-Hui Luo
Journal: Cardiovasc Diabetol Date: 2020-08-26 Impact factor: 9.951

7 in total

4 in total

1. The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study.

Authors: Yi-Hsin Chan; Tze-Fan Chao; Shao-Wei Chen; Hsin-Fu Lee; Pei-Ru Li; Wei-Min Chen; Yung-Hsin Yeh; Chi-Tai Kuo; Lai-Chu See; Gregory Y H Lip
Journal: Cardiovasc Diabetol Date: 2022-06-28 Impact factor: 8.949

Review 2. Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation.

Authors: Andreas S Papazoglou; Anastasios Kartas; Dimitrios V Moysidis; Christos Tsagkaris; Stavros P Papadakos; Alexandra Bekiaridou; Athanasios Samaras; Efstratios Karagiannidis; Marios Papadakis; George Giannakoulas
Journal: Cardiovasc Diabetol Date: 2022-03-14 Impact factor: 9.951

Review 3. Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents.

Authors: Bilin Xu; Zhiliang Li; Ting Zeng; Jianfeng Zhan; Shuzhen Wang; Chi-Tang Ho; Shiming Li
Journal: Molecules Date: 2022-03-28 Impact factor: 4.411

4. Effect of metformin on adverse outcomes in T2DM patients: Systemic review and meta-analysis of observational studies.

Authors: Zhicheng Xu; Haidong Zhang; Chenghui Wu; Yuxiang Zheng; Jingzhou Jiang
Journal: Front Cardiovasc Med Date: 2022-09-23

4 in total